Phibro Animal Health Stock Fundamentals
| PAHC Stock | USD 12.87 0.12 0.92% |
Phibro Animal Health fundamentals help investors to digest information that contributes to Phibro Animal's financial success or failures. It also enables traders to predict the movement of Phibro Stock. The fundamental analysis module provides a way to measure Phibro Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phibro Animal stock.
At present, Phibro Animal's Interest Expense is projected to decrease significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 89.9 M, whereas Selling General Administrative is forecasted to decline to about 133.1 M. Phibro | Select Account or Indicator |
Phibro Animal Health Company Return On Equity Analysis
Phibro Animal's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Phibro Animal Return On Equity | 0.0549 |
Most of Phibro Animal's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Phibro Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Phibro Animal Health has a Return On Equity of 0.0549. This is 100.23% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 117.71% lower than that of the firm.
Phibro Animal Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Phibro Animal's current stock value. Our valuation model uses many indicators to compare Phibro Animal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phibro Animal competition to find correlations between indicators driving Phibro Animal's intrinsic value. More Info.Phibro Animal Health is considered to be number one stock in return on equity category among related companies. It is regarded second in return on asset category among related companies reporting about 0.68 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Phibro Animal Health is roughly 1.48 . At present, Phibro Animal's Return On Equity is projected to slightly decrease based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value Phibro Animal by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Phibro Animal's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phibro Animal's earnings, one of the primary drivers of an investment's value.Phibro Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.Phibro Animal is currently under evaluation in return on equity category among related companies.
Phibro Fundamentals
| Return On Equity | 0.0549 | ||||
| Return On Asset | 0.0372 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 943.3 M | ||||
| Shares Outstanding | 20.34 M | ||||
| Shares Owned By Insiders | 0.62 % | ||||
| Shares Owned By Institutions | 99.38 % | ||||
| Number Of Shares Shorted | 706.15 K | ||||
| Price To Earning | 11.39 X | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 977.89 M | ||||
| Gross Profit | 298.24 M | ||||
| EBITDA | 108.49 M | ||||
| Net Income | 32.61 M | ||||
| Cash And Equivalents | 98.67 M | ||||
| Cash Per Share | 2.44 X | ||||
| Total Debt | 509.97 M | ||||
| Debt To Equity | 1.79 % | ||||
| Current Ratio | 2.97 X | ||||
| Book Value Per Share | 6.69 X | ||||
| Cash Flow From Operations | 13.31 M | ||||
| Short Ratio | 4.70 X | ||||
| Earnings Per Share | 0.37 X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 10.75 | ||||
| Number Of Employees | 1.92 K | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 526.14 M | ||||
| Total Asset | 971.4 M | ||||
| Retained Earnings | 260.91 M | ||||
| Working Capital | 409.72 M | ||||
| Current Asset | 342.83 M | ||||
| Current Liabilities | 108.78 M | ||||
| Annual Yield | 0.04 % | ||||
| Five Year Return | 1.85 % | ||||
| Net Asset | 971.4 M | ||||
| Last Dividend Paid | 0.48 |
About Phibro Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 63.2 M | 39.4 M | |
| Total Revenue | 1.1 B | 669.4 M | |
| Cost Of Revenue | 781.6 M | 479.4 M | |
| Stock Based Compensation To Revenue | (0.01) | (0.01) | |
| Sales General And Administrative To Revenue | 0.17 | 0.20 | |
| Research And Ddevelopement To Revenue | 0.02 | 0.02 | |
| Capex To Revenue | (0.06) | (0.06) | |
| Revenue Per Share | 21.73 | 12.21 | |
| Ebit Per Revenue | 0.07 | 0.06 |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Phibro Animal Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Phibro Animal Piotroski F Score and Phibro Animal Altman Z Score analysis. Note that the Phibro Animal Health information on this page should be used as a complementary analysis to other Phibro Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Phibro Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Dividend Share 0.48 | Earnings Share 0.37 | Revenue Per Share 24.245 | Quarterly Revenue Growth 0.022 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.